doi: 10.3389/fonc.2024.1388383.
eCollection 2024.
Retraction: Overexpressed tumor suppressor exosomal miR-15a-5p in cancer cells inhibits PD1 expression in CD8+T cells and suppresses the hepatocellular carcinoma progression
- PMID: 38505586
- PMCID: PMC10949859
- DOI: 10.3389/fonc.2024.1388383
Item in Clipboard
Retraction: Overexpressed tumor suppressor exosomal miR-15a-5p in cancer cells inhibits PD1 expression in CD8+T cells and suppresses the hepatocellular carcinoma progression
Front Oncol.
.
Abstract
[This retracts the article DOI: 10.3389/fonc.2021.622263.].
Copyright © 2024 Frontiers Editorial Office.
Retraction of
-
Overexpressed Tumor Suppressor Exosomal miR-15a-5p in Cancer Cells Inhibits PD1 Expression in CD8+T Cells and Suppresses the Hepatocellular Carcinoma Progression.Front Oncol. 2021 Mar 19;11:622263. doi: 10.3389/fonc.2021.622263. eCollection 2021. Front Oncol. 2021. Retraction in: Front Oncol. 2024 Mar 05;14:1388383. doi: 10.3389/fonc.2024.1388383. PMID: 33816255 Free PMC article. Retracted.
Similar articles
-
Overexpressed Tumor Suppressor Exosomal miR-15a-5p in Cancer Cells Inhibits PD1 Expression in CD8+T Cells and Suppresses the Hepatocellular Carcinoma Progression.Front Oncol. 2021 Mar 19;11:622263. doi: 10.3389/fonc.2021.622263. eCollection 2021. Front Oncol. 2021. Retraction in: Front Oncol. 2024 Mar 05;14:1388383. doi: 10.3389/fonc.2024.1388383. PMID: 33816255 Free PMC article. Retracted.
-
Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis.J Exp Clin Cancer Res. 2021 May 26;40(1):177. doi: 10.1186/s13046-021-01973-z. J Exp Clin Cancer Res. 2021. Retraction in: J Exp Clin Cancer Res. 2022 Apr 9;41(1):134. doi: 10.1186/s13046-022-02353-x. PMID: 34039401 Free PMC article. Retracted.
-
MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.Tumour Biol. 2016 May;37(5):5821-8. doi: 10.1007/s13277-015-4427-6. Epub 2015 Nov 18. Tumour Biol. 2016. PMID: 26581909
-
Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma.Mol Cancer. 2023 Mar 18;22(1):55. doi: 10.1186/s12943-023-01759-1. Mol Cancer. 2023. PMID: 36932387 Free PMC article.
-
Knockdown of circZMIZ1 enhances the anti-tumor activity of CD8+ T cells to alleviate hepatocellular carcinoma.Funct Integr Genomics. 2024 Feb 9;24(1):27. doi: 10.1007/s10142-024-01302-5. Funct Integr Genomics. 2024. PMID: 38332346
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
